Spectral karyotypic study of the HL-60 cell line: Detection of complex rearrangements involving chromosomes 5, 7, and 16 and delineation of critical region of deletion on 5q31.1

Cancer Genetics and Cytogenetics

Volumn 113, Issue 2, 1999, Pages 105-109

  Liang, Jan C ^a   Ning, Yi ^b   Wang, Rui yu ^a   Padilla Nash, Hesed M ^b   Schröck, Evelin ^b   Soenksen, Dirk ^c   Nagarajan, Lalitha ^a   Ried, Thomas ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c Applied Spectral Imaging Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL LINE; CELL STRAIN HL 60; CHROMOSOME 16; CHROMOSOME 5; CHROMOSOME 5Q; CHROMOSOME 7; CHROMOSOME REARRANGEMENT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; HUMAN CELL; KARYOTYPING; PRIORITY JOURNAL; SPECTRAL KARYOTYPING; SPECTROSCOPY; TECHNIQUE;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 7; GENE REARRANGEMENT; HL-60 CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; SEQUENCE DELETION; TRANSLOCATION, GENETIC;

BACTERIA (MICROORGANISMS);

EID: 0032805321     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00030-8     Document Type: Article

References (13)

1. Gallager R., Collins S., Trujillo J., McCreddie K., Ahearn M., Tsai S., Metzgar R., Aulakh G., Ting R., Ruscetti F., Gallo R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 54:1979;713-732.
2. Dalton W.T., Ahearn M.J., McCredie K.B., Freireich E.J., Stass A.S., Trujillo J.M. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood. 71:1988;242-247.
3. Le Beau M.M., Albain K.S., Larson R.A., Vardiman J.W., Davis E.M., Blough R.R., Golomb H.M., Rowley J.D. Clinical and cytogenetic correlations in 63 patients with therapy related myelodysplastic syndromes and acute nonlymphocytic leukemia. further evidence for characteristic abnormalities of chromosomes number 5 and 7 J Clin Oncol. 4:1986;325-345.
4. Le Beau M.M., Espinosa R. III, Neuman W.L., Stock W., Roulston D., Larson R.A., Keinanen M., Westbrook C.A. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci USA. 90:1993;5484-5488.
5. Nagarajan L. Molecular analysis of the 5q- chromosome. Leuk Lymphoma. 17:1995;361-366.
6. Fairman J., Chumakov I., Chinault C., Nowell P.C., Nagarajan L. Physical mapping of the critical 5q31 locus. Proc Natl Acad Sci USA. 92:1995;7406-7410.
7. Shipley J., Weber-Hall S., Birdsall S. Loss of the chromosomal region 5q11-q31 in the myeloid cell line HL-60. characterization by comparative genomic hybridization and fluorescence in situ hybridization Genes Chromosom Cancer. 15:1996;182-186.
8. Zavadil J., Brezinova J., Svoboda P., Zemanova Z., Michalova K. Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60. Leukemia. 11:1997;1187-1192.
9. Wolman S.R., Lanfrancone L., Della-Favera R., Ripley S., Henderson A.S. Oncogene mobility in human leukemia. Cancer Genet Cytogenet. 17:1985;133-141.
10. Schröck E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D., Garini Y., Ried T. Multicolor spectral karyotyping of human chromosomes. Science. 273:1996;494-497.
11. NIH-IMM collaboration A complete set of human telomeric probes and their clinical application. Nat Gene. 14:1996;86-89.
12. Nowell P., Finan J., Dalla Favera R., Gallo R.C., ar-Rushdi A., Romanczuk H., Selden J.R., Emanuel B.S., Rovera G., Croce C.M. Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukemic cell line. Nature. 306:1983;494-497.
13. Fairman J., Wang R.Y., Liang H., Zhao L., Saltman D., Liang J.C., Nagarajan L. Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia. evidence for a novel critical locus Blood. 88:1996;2259-2266.